サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542401

がん幹細胞の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Cancer Stem Cell Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
がん幹細胞の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん幹細胞市場の世界需要は、2023年の18億6,000万米ドルから2032年にはほぼ53億5,000万米ドルの市場規模に達すると推定され、調査期間2024-2032年のCAGRは12.43%です。

がん幹細胞は、腫瘍内で自己複製と分化を行い、元の腫瘍に見られる様々な細胞型に変化することができる細胞の小さなサブセットです。がん幹細胞は、腫瘍の成長を開始・維持し、従来のがん治療に抵抗し、体内の他の部位に転移する可能性があるなど、正常な幹細胞と類似した特徴を有しています。これらの細胞の存在は、しばしば腫瘍の再発や治療抵抗性と相関するため、これらの細胞を同定し標的とすることは、がん治療戦略において極めて重要です。腫瘍微小環境内での細胞の生物学的性質と相互作用を理解することは、がんを根本から根絶する効果的な治療法を開発するために不可欠です。

市場力学

がん幹細胞（CSCs）分野は、がん治療戦略を前進させる有望な道筋を提示しています。CSCの研究と治療に対する市場促進要因としては、がんの再発や従来の治療法に対する耐性におけるCSCの役割に対する理解の深まりが挙げられます。研究者がCSCsの分子的・遺伝的特徴を深く掘り下げるにつれて、腫瘍形成や転移の根本原因を特異的に根絶できる、より効果的な治療のターゲットとしての可能性がますます認識されるようになっています。さらに、がん幹細胞研究の市場機会は、技術の進歩と新規治療薬の開発によって拡大しています。製薬会社やバイオテクノロジー企業は、がん治療においてがん幹細胞を標的とすることの潜在的利益を活用することを目的として、がん幹細胞を標的とした薬剤の発見と開発に多額の投資を行っています。世界のがん罹患率の増加は、患者の転帰と生存率を改善できる革新的な治療アプローチが緊急に必要であることを強調しています。さらに、学術界、研究機関、業界関係者の協力は、基礎的なCSC研究を臨床応用につなげることを促進します。しかし、再発しにくい効果的な標的療法の開拓、規制上のハードル、治療費の大幅な増加が、予測期間中の市場成長の妨げになる可能性が高いです。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、がん幹細胞の世界市場における各セグメントを包括的に評価することもできます。がん幹細胞産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

がん幹細胞市場レポートのこのセクションでは、国別および地域別のセグメントに関する詳細なデータを提供し、それによって戦略担当者がそれぞれの製品またはサービスのターゲット層を特定する上で、今後のビジネスチャンスを支援します。

作用機序別

  • 標的がん幹細胞（CSCs）

抗CSC治療薬（経路阻害剤（WNTシグナル伝達経路、ヘッジホッグシグナル伝達経路、ノッチシグナル伝達経路、その他）、表面マーカーベース、免疫回避・腫瘍微小環境標的、ナノ粒子ベース、その他）、製品（細胞培養、細胞分離、細胞分析、分子分析、その他）別

  • 幹細胞を用いたがん治療（自己幹細胞移植、同種幹細胞移植）

がん形態別

  • 乳がん
  • 血液がん
  • 肺がん
  • 脳腫瘍
  • 大腸がん
  • 膵臓がん
  • 膀胱がん
  • 肝臓がん
  • その他のがん

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるがん幹細胞市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 がん幹細胞-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 がん幹細胞の世界市場分析：作用機序別

  • 作用機序別の概要
  • 作用機序別の過去および予測データ分析
  • 標的がん幹細胞（CSCs）

第6章 世界のがん幹細胞市場分析：抗CSC治療薬別（パスウェイ阻害薬（wntシグナル伝達経路、ヘッジホッグシグナル伝達経路、ノッチシグナル伝達経路、その他）、表面マーカーベース、免疫回避・腫瘍微小環境標的、ナノ粒子ベース治療、その他）、製品別（細胞培養、細胞分離、細胞分析、分子解析、その他）

  • 概要：抗CSC治療薬別（パスウェイ阻害薬（wntシグナル伝達経路、ヘッジホッグシグナル伝達経路、ノッチシグナル伝達経路、その他）、表面マーカーベース、免疫回避・腫瘍微小環境標的、ナノ粒子ベース治療、その他）、製品別（細胞培養、細胞分離、細胞分析、分子解析、その他）
  • 過去および予測データ分析：抗CSC治療薬別（パスウェイ阻害薬（wntシグナル伝達経路、ヘッジホッグシグナル伝達経路、ノッチシグナル伝達経路、その他）、表面マーカーベース、免疫回避・腫瘍微小環境標的、ナノ粒子ベース治療、その他）、製品別（細胞培養、細胞分離、細胞分析、分子解析、その他）
  • 幹細胞を用いたがん治療（自己幹細胞移植、同種幹細胞移植）

第7章 世界のがん幹細胞市場分析：がん形態別

  • がん形態別概要
  • 過去および予測データ分析：がん形態別
  • 乳がん
  • 血液がん
  • 肺がん
  • 脳腫瘍
  • 大腸がん
  • 膵臓がん
  • 膀胱がん
  • 肝臓がん
  • その他のがん

第8章 世界のがん幹細胞市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋地域セグメント別
    • アジア太平洋地域国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 がん幹細胞企業の競合情勢

  • がん幹細胞市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics Inc.
  • OncoMed Pharmaceuticals Inc.
  • Fujifilm Irvine Scientific
  • Stemcell Technologies.
  • Sino Biological Inc.
  • Lineage Cell Therapeutics Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Mode of Action (USD MN)
  • Targeted Cancerous Stem Cells (CSCs) Market Sales By Geography (USD MN)
  • ( Market Sales By Geography (USD MN)
  • Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others) (USD MN)
  • Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Market Sales By Geography (USD MN)
  • Analysis By Cancer Forms (USD MN)
  • Breast cancer Market Sales By Geography (USD MN)
  • Blood cancer Market Sales By Geography (USD MN)
  • Lung cancer Market Sales By Geography (USD MN)
  • Brain cancer Market Sales By Geography (USD MN)
  • Colorectal cancer Market Sales By Geography (USD MN)
  • Pancreatic cancer Market Sales By Geography (USD MN)
  • Bladder cancer Market Sales By Geography (USD MN)
  • Liver cancer Market Sales By Geography (USD MN)
  • Others cancer Market Sales By Geography (USD MN)
  • Global Cancer Stem Cell Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Stem Cell Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Stem Cell Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Mode of Action
  • Market Attractiveness Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
  • Market Attractiveness Analysis By Cancer Forms
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Mode of Action (USD MN)
  • Targeted Cancerous Stem Cells (CSCs) Market Sales By Geography (USD MN)
  • ( Market Sales By Geography (USD MN)
  • Global Market Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others) (USD MN)
  • Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer Forms (USD MN)
  • Breast cancer Market Sales By Geography (USD MN)
  • Blood cancer Market Sales By Geography (USD MN)
  • Lung cancer Market Sales By Geography (USD MN)
  • Brain cancer Market Sales By Geography (USD MN)
  • Colorectal cancer Market Sales By Geography (USD MN)
  • Pancreatic cancer Market Sales By Geography (USD MN)
  • Bladder cancer Market Sales By Geography (USD MN)
  • Liver cancer Market Sales By Geography (USD MN)
  • Others cancer Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219676

The global demand for Cancer Stem Cell Market is presumed to reach the market size of nearly USD 5.35 Billion by 2032 from USD 1.86 Billion in 2023 with a CAGR of 12.43% under the study period 2024-2032.

Cancer stem cells are a small subset of cells within tumors capable of self-renewal and differentiation into various cell types found in the original tumor. They possess characteristics similar to normal stem cells, such as initiating and sustaining tumor growth, resisting conventional cancer therapies, and potentially metastasizing to other parts of the body. Identifying and targeting these cells is crucial in cancer treatment strategies, as their presence often correlates with tumor recurrence and treatment resistance. Understanding their biology and interactions within the tumor microenvironment is essential for developing effective therapies to eradicate cancer at its root.

MARKET DYNAMICS

The cancer stem cells (CSCs) field presents a promising avenue for advancing cancer treatment strategies. Market drivers for CSC research and therapies include the growing understanding of CSCs' role in cancer recurrence and resistance to traditional therapies. As researchers delve deeper into the molecular & genetic characteristics of CSCs, they increasingly recognize their potential as targets for more effective treatments that can specifically eradicate the root cause of tumor formation and metastasis. Moreover, the market opportunities in cancer stem cell research are expanding with advancements in technology and the development of novel therapeutics. Pharmaceutical companies & biotech firms are investing heavily in CSC-targeted drug discovery and development, aiming to capitalize on the potential benefits of targeting cancer stem cells in cancer therapy. The rising prevalence of cancer worldwide further underscores the urgent need for innovative treatment approaches that can improve patient outcomes and survival rates. Furthermore, collaborations between academia, research institutes, and industry players facilitate translating basic CSC research into clinical applications. However, the development of effective targeted therapies resistant to relapse, regulatory hurdles, and significantly increasing cost of therapy will likely hamper market growth during the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cancer Stem Cell. The growth and trends of Cancer Stem Cell industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cancer Stem Cell market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Mode of Action

  • Targeted Cancerous Stem Cells (CSCs)
  • (

By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)

  • Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant)

By Cancer Forms

  • Breast cancer
  • Blood cancer
  • Lung cancer
  • Brain cancer
  • Colorectal cancer
  • Pancreatic cancer
  • Bladder cancer
  • Liver cancer
  • Others cancer

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Stem Cell market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Stem Cell market include Thermo Fisher Scientific Inc., AbbVie Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics Inc., Miltenyi Biotec, PromoCell GmbH, MacroGenics Inc., OncoMed Pharmaceuticals Inc., Fujifilm Irvine Scientific, Stemcell Technologies., Sino Biological Inc., Lineage Cell Therapeutics Inc., . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER STEM CELL - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Mode of Action
    • 3.7.2 Market Attractiveness Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
    • 3.7.3 Market Attractiveness Analysis By Cancer Forms
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY MODE OF ACTION

  • 5.1. Overview By Mode of Action
  • 5.2. Historical and Forecast Data Analysis By Mode of Action
  • 5.3. Targeted Cancerous Stem Cells (CSCs) Historic and Forecast Sales By Regions
  • 5.4. ( Historic and Forecast Sales By Regions

6. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY ANTI-CSC THERAPEUTICS (PATHWAY INHIBITORS (WNT SIGNALING PATHWAY, HEDGEHOG SIGNALING PATHWAY, NOTCH SIGNALING PATHWAY, OTHERS), SURFACE MARKER-BASED, IMMUNO-EVASION & TARGETING TUMOR MICROENVIRONMENT, NANOPARTICLE-BASED THERAPIES, OTHERS), PRODUCTS (CELL-CULTURING CELL-SEPARATION CELL ANALYSIS MOLECULAR ANALYSIS OTHERS)

  • 6.1. Overview By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
  • 6.2. Historical and Forecast Data Analysis By Anti-CSC Therapeutics (Pathway Inhibitors (WNT Signaling Pathway, Hedgehog Signaling Pathway, Notch Signaling Pathway, Others), Surface Marker-based, Immuno-evasion & Targeting Tumor Microenvironment, Nanoparticle-based Therapies, Others), Products (Cell-Culturing Cell-Separation Cell Analysis Molecular Analysis Others)
  • 6.3. Stem Cell-based Cancer Therapy (Autologous SC Transplant, Allogeneic SC Transplant) Historic and Forecast Sales By Regions

7. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY CANCER FORMS

  • 7.1. Overview By Cancer Forms
  • 7.2. Historical and Forecast Data Analysis By Cancer Forms
  • 7.3. Breast cancer Historic and Forecast Sales By Regions
  • 7.4. Blood cancer Historic and Forecast Sales By Regions
  • 7.5. Lung cancer Historic and Forecast Sales By Regions
  • 7.6. Brain cancer Historic and Forecast Sales By Regions
  • 7.7. Colorectal cancer Historic and Forecast Sales By Regions
  • 7.8. Pancreatic cancer Historic and Forecast Sales By Regions
  • 7.9. Bladder cancer Historic and Forecast Sales By Regions
  • 7.10. Liver cancer Historic and Forecast Sales By Regions
  • 7.11. Others cancer Historic and Forecast Sales By Regions

8. GLOBAL CANCER STEM CELL MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER STEM CELL COMPANIES

  • 9.1. Cancer Stem Cell Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CANCER STEM CELL INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. AbbVie Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bionomics
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Lonza
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Stemline Therapeutics Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Miltenyi Biotec
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. PromoCell GmbH
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. MacroGenics Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. OncoMed Pharmaceuticals Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Fujifilm Irvine Scientific
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Stemcell Technologies.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Sino Biological Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Lineage Cell Therapeutics Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17.
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies